Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.
The ECHO trial faces backlash and criticism.
Activists working on human rights discuss the challenges of achieving an end to the HIV epidemic.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.
PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.
In a study of more than 1,400 women living with HIV, nearly 30% did not achieve viral suppression and some groups of women had greater challenges with adherence and staying in care.
UNAIDS Announces 18.2 Million People on Antiretroviral Therapy, but Warns That 15-24 Years of Age Is a Highly Dangerous Time for Young Women
A new UNAIDS report shows that people are particularly vulnerable to HIV at certain points in their lives and calls for a life-cycle approach to find solutions for everyone at every stage of life.
Three studies conducted by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in rural and urban sub-districts of the KwaZulu-Natal province provide new insights into the engine that drives HIV transmission in the country. They a...